Lusmose

Lusmose is an oral medication containing Sunitinib, used for targeted therapy. It is manufactured by Egis Pharmaceuticals Plc and is available in the EU market.

Lusmose, containing the active ingredient Sunitinib, is primarily used for targeted therapy in certain types of cancer. It works by inhibiting specific proteins that can help cancer cells grow. People often ask, 'What is Lusmose used for?' and the answer is that it is typically prescribed for conditions where targeted therapy is beneficial.

Common effects of Lusmose may include fatigue, nausea, and skin discoloration. Some users might experience changes in their blood pressure or appetite. These effects can vary from person to person.

Lusmose should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women or those planning to become pregnant should discuss the use of Lusmose with their healthcare provider.

Lusmose may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking. Alcohol and other substances may also interact with Lusmose, so it is important to be aware of potential interactions.